Resumen
Radiotherapy plays a vital role in the multimodal treatment of pediatric central nervous system (CNS) tumors. In cases of small-to-medium-sized, well-demarcated lesions, high-precision treatment modalities such as stereotactic radiosurgery (SRS) are well-established in adult patients. SRS and, more specifically, robotic radiosurgery (RRS) and robotic stereotactic radiotherapy (RSRT) have only limited evidence in the field of pediatric neuro-oncology. This systematic review aims to report and assess the available RRS and RSRT data and studies. Results demonstrate that both treatment modalities are infrequently applied and primarily used in specific situations, including postoperative, palliative, and salvage treatments. Treatment outcomes are encouraging, but high-quality studies are lacking. Prospective studies are necessary to determine the actual utility of RRS and RSRT in pediatric neuro-oncology. Nevertheless, RRS and RSRT may be applied for selected patients.